A Treatment Protocol For Patients Continuing From A Prior SU011248 Protocol

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Duration of Treatment

Outcome Time Frame:

Baseline up to Day 28 after last dose of study treatment

Safety Issue:

Yes

Principal Investigator

Pfizer CT.gov Call Center

Investigator Role:

Study Director

Investigator Affiliation:

Pfizer

Authority:

United States: Food and Drug Administration

Study ID:

A6181030

NCT ID:

NCT00798889

Start Date:

March 2004

Completion Date:

December 2011

Related Keywords:

• Solid Tumors
• Solid tumors